Increase in hypoglycemic admissions: California hospital discharge data

Ethnicity and Disease

Volumn 17, Issue 3, 2007, Pages 536-540

  Asuncion, Merlyn M ^a,b   Shaheen, Magda ^a   Ganesan, Kalpana ^a   Velasques, Joseph ^a   Teklehaimanot, Senait ^a   Pan, Deyu ^a   Norris, Keith ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b KING DREW MEDICAL CENTER   (United States)

Author keywords

Diabetes; Hospital admissions; Hypoglycemia

Indexed keywords

ADULT; AGE; ARTICLE; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT EDUCATION; RACE DIFFERENCE; SELF MONITORING; SEX DIFFERENCE; SYMPTOMATOLOGY; UNITED STATES;

ADULT; CALIFORNIA; DATABASES AS TOPIC; DIABETES MELLITUS; FEMALE; HOSPITALIZATION; HUMANS; HYPOGLYCEMIA; MALE; MEDICAL RECORDS; MIDDLE AGED; PATIENT DISCHARGE;

EID: 35349026275     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Hogan P, Dall T, Nikolov P, and the American Diabetes Association. Economic costs of diabetes in the U.S. in 2002. Diabetes Care. 2003;26:917-932.
2. Leese GP, Wang J, Broomhall J. Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: A population-based study of health service resource use. Diabetes Care. 2003;26:1176-1180.
3. Palmer AJ, Weiss C, Sendi PP, et al. The cost-effectiveness of different management strategies for type 1 diabetes: a Swiss perspective. Diabetologia. 2000;43:13-26.
4. Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26(6):1902-1912.
5. Juurlink DN, Mamdani M, Kopp A, Laupacis A, Redelmeier DA. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA. 2003;289(13):1652-1658.
6. Jorgensen HV, Pedersen-Bjergaard U, Rasmussen AK, Borch-Johnsen K. The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care. 2003;26:1106-1109.
7. Holstein A, Plaschke A, Vogel MY, Egberts EH. Prehospital management of diabetic emergencies-a population-based intervention study. Acta Anaesthesiol Scand. 2003;47:610-615.
8. Frier BM. Epidemiology, short and long-term consequences of hypoglycaemia. Diabetes Nutr Metab. 2002;15(6):378-384.
9. Jones TW, Davis EA. Hypoglycemia in children with type 1 diabetes: current issues and controversies. Pediatr Diabetes. 2003;4(3):143-150.
10. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellirus. N Engl J. 1993;29:977-986.
11. Meux EF, Stith SA, Zach A. Report of resulrs from the OSHPD reabstracts project: an evaluation of the reliability of selected patient discharge data July through December 1988. Sacramento: Patient discharge data section. Office of Statewide Health Planning and Development. State of California. 1990.
12. Gray A, Raikou M, McGuire A, Fenn P, Stevens R, Cull C, Stratton I, Adler A, Holman R, Turner R. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomized controlled trial (UKPDS 41). BMJ. 2000;20:1373-1378.
13. Koro C. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes. Diabetes Care. 2004;27:17-20.
14. Saadine J. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144:465-474.
15. Marks JB. Treating hypertension in diabetics: data and perspectives. Clin Diabetes. 1999;17(4):148.
16. Puri D, Prabhu KM, Murthy PS. Mechanism of action of a hypoglycemic principle isolated from fenugreek seeds. Indian J Physiol Pharmacol. 2002;46(4):457-462.
17. Friedrich LV, Dougherty R. Fatal hypoglycemia associated with levofloxacin. Pharmacotherapy. 2004;12:1807-1812.
18. Biggs WS. Hypoglycemia and hyperglycemia associated with gatifloxacin use in elderly patients. J Am Board Fam Pract. 2003;16(5):455-457.
19. Amiel SA. Hypoglycaemia in the elderly: presentation, counterregulation, cognitive function and prevention. Diabetes Nutr Metab. 2002;15(6):451-454.
20. Cryer PE. Hypoglycaemia: the limiting factor in the glycaemic management of type 1 and type 2 diabetes. Diabetologia. 2002;45:937-948.
21. The United Kingdom Prospective Diabetes Study Research Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998;352:837-853.
22. Miller CD, Phillips LS, Ziemer DC, et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med. 2001;161:1653-1659.